Folgen
Frederic St-Onge
Frederic St-Onge
PhD Candidate, Integrated Program in Neuroscience, McGill University
Bestätigte E-Mail-Adresse bei mail.mcgill.ca - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ...
The Lancet Neurology 19 (2), 145-156, 2020
2962020
Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment
C Strikwerda-Brown, DA Hobbs, J Gonneaud, F St-Onge, AP Binette, ...
JAMA neurology 79 (10), 975-985, 2022
802022
Alcohol and drug use before and during the first year after traumatic brain injury
S Beaulieu-Bonneau, F St-Onge, MC Blackburn, A Banville, ...
The Journal of head trauma rehabilitation 33 (3), E51-E60, 2018
512018
Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease
Y Yakoub, NJ Ashton, C Strikwerda‐Brown, L Montoliu‐Gaya, TK Karikari, ...
Alzheimer's & Dementia 19 (12), 5620-5631, 2023
322023
Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition
H Ozlen, AP Binette, T Köbe, PF Meyer, J Gonneaud, F St-Onge, ...
JAMA neurology 79 (10), 1025-1035, 2022
182022
Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers
MTM Clarke, F St-Onge, JM Beauregard, M Bocchetta, E Todd, DM Cash, ...
Alzheimer's Research & Therapy 13, 1-8, 2021
172021
Schizophrenia phenotype preceding behavioral variant frontotemporal dementia related to C9orf72 repeat expansion
L Sellami, F St-Onge, S Poulin, R Laforce Jr
Cognitive and Behavioral Neurology 32 (2), 120-123, 2019
162019
Tau accumulation and its spatial progression across the Alzheimer’s disease spectrum
F St-Onge, M Chapleau, JCS Breitner, S Villeneuve, A Pichet Binette, ...
Brain Communications, fcae031, 2024
122024
How do modifiable risk factors affect Alzheimer’s disease pathology or mitigate its effect on clinical symptom expression?
V Ourry, AP Binette, F St-Onge, C Strikwerda-Brown, A Chagnot, J Poirier, ...
Biological psychiatry 95 (11), 1006-1019, 2024
92024
Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic …
RJ Laforce, C Dallaire-Théroux, AM Racine, G Dent, ...
Journal of Neurology 269 (7), 3579-3587, 2022
82022
Structural white matter properties and cognitive resilience to tau pathology
T Qiu, ZQ Liu, F Rheault, JH Legarreta, A Valcourt Caron, F St‐Onge, ...
Alzheimer's & Dementia 20 (5), 3364-3377, 2024
52024
Functional connectome fingerprinting across the lifespan
F St-Onge, M Javanray, A Pichet Binette, C Strikwerda-Brown, J Remz, ...
Network Neuroscience 7 (3), 1206-1227, 2023
52023
Plasma p-tau217 predicts cognitive impairments up to ten years before onset in normal older adults
Y Yakoub, F Gonzalez-Ortiz, NJ Ashton, C Déry, C Strikwerda-Brown, ...
medRxiv, 2024.05. 09.24307120, 2024
32024
Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease
Y Yakoub, NJ Ashton, C Strikwerda‐Brown, L Montoliu‐Gaya, TK Karikari, ...
Alzheimer's & Dementia 19 (12), 5620-5631, 2023
22023
Associations between psychological factors, grey matter volume, and resistance and resilience to tau pathology in cognitively unimpaired older adults
C Strikwerda‐Brown, F St‐Onge, Y Yakoub, H Ozlen, AP Binette, ...
Alzheimer's & Dementia 18, e064727, 2022
12022
Perceived needs, barriers, access to mental health services and self-management strategies for psychological health issues in the first year after traumatic brain injury …
F St-Onge, S Beaulieu-Bonneau, MC Ouellet
BRAIN INJURY 31 (6-7), 731-732, 2017
12017
The role of biofluid markers in predicting near‐term cognitive impairment
Y Yakoub, F Gonzalez‐Ortiz, NJ Ashton, TK Karikari, C Strikwerda‐Brown, ...
Alzheimer's & Dementia 20, e094038, 2024
2024
A‐T+ PET participants in preclinical AD: Clinical progression and concordance with fluid markers
Y Yakoub, F St‐Onge, A Fajardo, B Mohammediyan, C Dery, E Sylvain, ...
Alzheimer's & Dementia 20, e092369, 2024
2024
Brain Functional Flexibility and its Relationship to the Preclinical Stage of Alzheimer’s Disease
M Javanray, F St‐Onge, P Bellec, B Misic, JP Soucy, S Villeneuve, ...
Alzheimer's & Dementia 20, e091900, 2024
2024
Multicenter Validation of the English Version of the Dépistage Cognitif de Québec: a Cognitive Screening Tool for Atypical Dementias
S Meilleur-Durand, M Lévesque, F St-Onge, M Masellis, GYR Hsiung, ...
Archives of Clinical Neuropsychology, acae092, 2024
2024
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20